PureTech News

Press releases
Press Releases - 2023-11-29
Other
Karuna
PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia
Press Releases - 2023-11-17
Other
Karuna
PureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in Schizophrenia
Press Releases - 2023-11-14
Wholly Owned Pipeline - LYT-300
Other
PureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy Volunteers
Press Releases - 2023-10-17
Other
PureTech to Present at Two Upcoming Investor Conferences
Press Releases - 2023-10-11
Wholly Owned Pipeline - LYT-100
Other
PureTech Presents Data from LYT-100 (Deupirfenidone) Trial in Healthy Older Adults at CHEST Annual Meeting
Press Releases - 2023-10-04
Other
Vedanta
PureTech Founded Entity Vedanta Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of VE202 for the Treatment of Ulcerative Colitis and Receives Fast Track Designation
Press Releases - 2023-09-28
Other
Karuna
KarXT, invented at PureTech, submitted for FDA Approval in Schizophrenia
Press Releases - 2023-09-27
Other
PureTech Announces the Appointment of Robert Lyne as Chief Portfolio Officer
Press Releases - 2023-08-29
Wholly Owned Pipeline
Other
PureTech Health plc - Half-Year Report
Press Releases - 2023-08-22
Other
Notice of Half-Yearly Results
Displaying 1 - 10 of 356

Sign up for email alerts

To receive news as it is released, please sign up.

@PureTechH